首页 > 最新文献

Brain & Development最新文献

英文 中文
Glass syndrome derived from chromosomal breakage downstream region of SATB2 格拉斯综合征源于 SATB2 下游区域的染色体断裂。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-07-06 DOI: 10.1016/j.braindev.2024.06.003

Background

Glass syndrome, derived from chromosomal 2q33.1 microdeletions, manifests with intellectual disability, microcephaly, epilepsy, and distinctive features, including micrognathia, down-slanting palpebral fissures, cleft palate, and crowded teeth. Recently, SATB2 located within the deletion region, was identified as the causative gene responsible for Glass syndrome. Numerous disease-causing variants within the SATB2 coding region have been reported.

Objective

Given the presentation of intellectual disability and multiple congenital anomalies in a patient with a de novo reciprocal translocation between chromosomes 1 and 2, disruption of the causative gene(s) was suspected. This study sought to identify the causative gene in the patient.

Methods

Long-read whole-genome sequencing was performed, and the expression level of the candidate gene was analyzed.

Results

The detection of breakpoints was successful. While the breakpoint on chromosome 1 disrupted RNF220, it was not deemed to be a genetic cause. Conversely, SATB2 is located in the approximately 100-kb telomeric region of the breakpoint on chromosome 2. The patient’s clinical features resembled those of previously reported cases of Glass syndrome, despite the lack of confirmed reduced SATB2 expression.

Conclusion

The patient was diagnosed with Glass syndrome due to the similarity in clinical features. This led us to hypothesize that disruption in the downstream region of SATB2 could result in Glass syndrome. The microhomologies identified in the breakpoint junctions indicate a potential molecular mechanism involving microhomology-mediated break-induced repair mechanism or template switching.

背景:格拉斯综合征源于染色体 2q33.1 微缺失,表现为智力障碍、小头畸形、癫痫和独特的特征,包括小颌畸形、下斜睑裂、腭裂和牙齿拥挤。最近,位于缺失区的 SATB2 被确定为导致格拉斯综合征的致病基因。据报道,SATB2 编码区内存在大量致病变异:鉴于一名在 1 号染色体和 2 号染色体之间存在新发互易位点的患者表现出智力障碍和多种先天性畸形,因此怀疑致病基因发生了破坏。本研究试图确定该患者的致病基因:方法:进行长线程全基因组测序,分析候选基因的表达水平:结果:断点检测成功。虽然 1 号染色体上的断点破坏了 RNF220,但并未被认为是遗传原因。相反,SATB2位于2号染色体断点的约100kb端粒区。尽管没有证实 SATB2 表达减少,但患者的临床特征与之前报道的格拉斯综合征病例相似:结论:由于临床特征相似,该患者被诊断为格拉斯综合征。结论:由于临床特征相似,该患者被诊断为格拉斯综合征,这使我们推测 SATB2 下游区域的破坏可能导致格拉斯综合征。在断点连接处发现的微组构表明,潜在的分子机制涉及微组构介导的断裂诱导修复机制或模板转换。
{"title":"Glass syndrome derived from chromosomal breakage downstream region of SATB2","authors":"","doi":"10.1016/j.braindev.2024.06.003","DOIUrl":"10.1016/j.braindev.2024.06.003","url":null,"abstract":"<div><h3>Background</h3><p><span>Glass syndrome, derived from chromosomal 2q33.1 microdeletions, manifests with intellectual disability, microcephaly, epilepsy, and distinctive features, including micrognathia, down-slanting palpebral fissures, cleft palate, and crowded teeth. Recently, </span><span><em>SATB2</em></span> located within the deletion region, was identified as the causative gene responsible for Glass syndrome. Numerous disease-causing variants within the <em>SATB2</em><span> coding region have been reported.</span></p></div><div><h3>Objective</h3><p>Given the presentation of intellectual disability and multiple congenital anomalies in a patient with a de novo reciprocal translocation<span> between chromosomes 1 and 2, disruption of the causative gene(s) was suspected. This study sought to identify the causative gene in the patient.</span></p></div><div><h3>Methods</h3><p>Long-read whole-genome sequencing was performed, and the expression level of the candidate gene was analyzed.</p></div><div><h3>Results</h3><p>The detection of breakpoints was successful. While the breakpoint on chromosome 1 disrupted <em>RNF220</em><span>, it was not deemed to be a genetic cause. Conversely, </span><em>SATB2</em> is located in the approximately 100-kb telomeric region of the breakpoint on chromosome 2. The patient’s clinical features resembled those of previously reported cases of Glass syndrome, despite the lack of confirmed reduced <em>SATB2</em> expression.</p></div><div><h3>Conclusion</h3><p>The patient was diagnosed with Glass syndrome due to the similarity in clinical features. This led us to hypothesize that disruption in the downstream region of <em>SATB2</em><span> could result in Glass syndrome. The microhomologies identified in the breakpoint junctions indicate a potential molecular mechanism involving microhomology-mediated break-induced repair mechanism or template switching.</span></p></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"46 9","pages":"Pages 281-285"},"PeriodicalIF":1.4,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141556095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological study on pediatric-onset dystonia in Japan: A questionnaire-based survey 日本小儿肌张力障碍流行病学研究:基于问卷的调查。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-06-27 DOI: 10.1016/j.braindev.2024.06.002

Objective

This study aimed to investigate the clinical characteristics of pediatric-onset dystonia in Japan, addressing the diagnostic challenges arising from symptom variations and etiological diversity.

Methods

From 2020 to 2022, questionnaires were distributed to 1218 board certified child neurologists (BCCNs) by Japanese Society of Child Neurology. In the primary survey, participants were asked to report the number of patients with pediatric-onset dystonia under their care. Subsequently, the follow-up secondary survey sought additional information on the clinical characteristics of these patients.

Results

The primary survey obtained 550 responses (response rate: 45 %) from BCCNs for their 736 patients with dystonia. The predominant etiologies included inherited cases (with DYT10  <PxMD-PRRT2> being the most prevalent, followed by DYT5 <DYT/PARK-GCH1> and ATP1A3-related neurologic disorders), acquired cases (with perinatal abnormalities being the most common), and idiopathic cases. The secondary survey provided clinical insights into 308 cases from 82 BCCNs. Infancy-onset dystonia presented as persistent and generalized with diverse symptoms, primarily linked to ATP1A3-related neurologic disorders and other genetic disorders resembling acquired dystonia. Conversely, childhood/adolescent-onset dystonia showed paroxysmal, fluctuating courses, predominantly affecting limbs. The most common etiologies were DYT5 <DYT/PARK-GCH1> and DYT10 <PxMD-PRRT2>, leading to therapeutic diagnoses.

Conclusion

Pediatric-onset dystonia in Japan was treated by 28 % of BCCNs. The majority of cases were inherited, with high prevalence rates of DYT5 <DYT/PARK-GCH1> and DYT10 <PxMD-PRRT2>. Infancy-onset dystonia exhibits diverse etiologies and symptoms, emphasizing the utility of various examinations, including genetic testing. These findings significantly contribute to our understanding of pediatric-onset dystonia in Japan, although this study has the limitation of questionnaire survey.

研究目的本研究旨在调查日本小儿肌张力障碍的临床特征,解决因症状变化和病因多样性而产生的诊断难题:从 2020 年到 2022 年,日本儿童神经病学学会向 1218 名经委员会认证的儿童神经病学家(BCCN)发放了调查问卷。在初级调查中,参与者被要求报告在其治疗下的小儿肌张力障碍患者人数。随后进行的后续二次调查则要求提供有关这些患者临床特征的更多信息:主要调查从 BCCN 获得了 550 份回复(回复率:45%),涉及 736 名肌张力障碍患者。主要病因包括遗传性病例(DYT10最为常见,其次是DYT5和ATP1A3相关神经系统疾病)、获得性病例(围产期异常最为常见)和特发性病例。二次调查提供了来自 82 个 BCCN 的 308 个病例的临床资料。婴儿期发病的肌张力障碍表现为持续性和全身性,症状多样,主要与 ATP1A3 相关神经系统疾病和其他类似获得性肌张力障碍的遗传疾病有关。相反,儿童/青少年期肌张力障碍表现为阵发性、波动性病程,主要累及四肢。最常见的病因是 DYT5 和 DYT10,从而导致治疗性诊断:结论:在日本,28%的 BCCN 治疗过小儿肌张力障碍。大多数病例是遗传性的,DYT5 和 DYT10 的发病率很高。婴幼儿期肌张力障碍的病因和症状多种多样,因此需要进行包括基因检测在内的各种检查。尽管本研究存在问卷调查的局限性,但这些发现极大地促进了我们对日本儿童发病型肌张力障碍的了解。
{"title":"Epidemiological study on pediatric-onset dystonia in Japan: A questionnaire-based survey","authors":"","doi":"10.1016/j.braindev.2024.06.002","DOIUrl":"10.1016/j.braindev.2024.06.002","url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed to investigate the clinical characteristics of pediatric-onset dystonia in Japan, addressing the diagnostic challenges arising from symptom variations and etiological diversity.</p></div><div><h3>Methods</h3><p>From 2020 to 2022, questionnaires were distributed to 1218 board certified child neurologists (BCCNs) by Japanese Society of Child Neurology. In the primary survey, participants were asked to report the number of patients with pediatric-onset dystonia under their care. Subsequently, the follow-up secondary survey sought additional information on the clinical characteristics of these patients.</p></div><div><h3>Results</h3><p>The primary survey obtained 550 responses (response rate: 45 %) from BCCNs for their 736 patients with dystonia. The predominant etiologies included inherited cases (with DYT10  &lt;PxMD-<em>PRRT2</em>&gt; being the most prevalent, followed by DYT5 &lt;DYT/PARK-<em>GCH1</em>&gt; and <em>ATP1A3</em>-related neurologic disorders), acquired cases (with perinatal abnormalities being the most common), and idiopathic cases. The secondary survey provided clinical insights into 308 cases from 82 BCCNs. Infancy-onset dystonia presented as persistent and generalized with diverse symptoms, primarily linked to <em>ATP1A3</em>-related neurologic disorders and other genetic disorders resembling acquired dystonia. Conversely, childhood/adolescent-onset dystonia showed paroxysmal, fluctuating courses, predominantly affecting limbs. The most common etiologies were DYT5 &lt;DYT/PARK-<em>GCH1</em>&gt; and DYT10 &lt;PxMD-<em>PRRT2</em>&gt;, leading to therapeutic diagnoses.</p></div><div><h3>Conclusion</h3><p>Pediatric-onset dystonia in Japan was treated by 28 % of BCCNs. The majority of cases were inherited, with high prevalence rates of DYT5 &lt;DYT/PARK-<em>GCH1</em>&gt; and DYT10 &lt;PxMD-<em>PRRT2</em>&gt;. Infancy-onset dystonia exhibits diverse etiologies and symptoms, emphasizing the utility of various examinations, including genetic testing. These findings significantly contribute to our understanding of pediatric-onset dystonia in Japan, although this study has the limitation of questionnaire survey.</p></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"46 8","pages":"Pages 274-279"},"PeriodicalIF":1.4,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0387760424000949/pdfft?md5=1dd733b80e076b5e12f46a2ffd25367c&pid=1-s2.0-S0387760424000949-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover 封面
IF 1.7 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-06-13 DOI: 10.1016/S0387-7604(24)00082-2
{"title":"Cover","authors":"","doi":"10.1016/S0387-7604(24)00082-2","DOIUrl":"https://doi.org/10.1016/S0387-7604(24)00082-2","url":null,"abstract":"","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"46 7","pages":"Page IBC"},"PeriodicalIF":1.7,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0387760424000822/pdfft?md5=854145fc76587376a19d68430464286c&pid=1-s2.0-S0387760424000822-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141313373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum 25(OH)D and vitamin K1 levels in patients with severe motor and intellectual disability: A Japanese single-center experience 严重运动障碍和智力障碍患者的血清 25(OH)D 和维生素 K1 水平:日本单中心经验。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-06-13 DOI: 10.1016/j.braindev.2024.06.001

Purpose

To investigate whether patients with severe motor and intellectual disability (SMID) have nutritional vitamin D and K insufficiencies and clarify the required vitamin supplementation.

Methods

This prospective observational study enrolled Japanese adults with SMID receiving institutionalized care who underwent blood sampling between February 2020 and February 2022 during annual medical checkups. Serum vitamin K1 and 25-hydroxy vitamin D (25(OH)D) levels were measured to determine their relationship with serum uncarboxylated osteocalcin (ucOC) levels. Vitamin D and K intake was compared among tube-fed and oral-intake patients with SMID and control participants using corresponding serum levels.

Results

The study included 124 patients with SMID (56 men and 68 women; mean age: 53.0 years) and 20 control participants. Serum 25(OH)D levels were significantly higher in the SMID group than in the control group and the oral intake SMID group than in the tube-fed SMID group. In the tube-fed SMID group, vitamin D intake was lower than the daily recommended intake and correlated with serum 25(OH)D levels. Daily vitamin K intake in the tube-fed group was lower than recommended but not correlated with serum vitamin K levels. Serum ucOC levels were significantly higher in the SMID group than in the control group. Tube feeding was significantly and positively correlated with serum 25(OH)D levels. Serum 25(OH)D levels were not correlated with serum vitamin K1 levels.

Conclusions

The SMID group had higher ucOC levels than the control group, possibly owing to daily vitamin K and D deficiencies. Vitamin D supplementation is recommended to decrease ucOC levels.

目的:调查严重运动和智力障碍(SMID)患者是否存在营养性维生素 D 和 K 不足的问题,并明确所需的维生素补充剂:这项前瞻性观察研究招募了接受机构护理的日本成年重度运动与智力障碍(SMID)患者,这些患者在 2020 年 2 月至 2022 年 2 月期间接受年度体检时接受了血液采样。测量血清维生素 K1 和 25- 羟基维生素 D(25(OH)D)水平,以确定它们与血清非羧化骨钙素(ucOC)水平的关系。使用相应的血清水平比较了管饲和口服维生素 D 和 K 摄入量的 SMID 患者和对照组参与者:研究包括 124 名 SMID 患者(56 名男性和 68 名女性;平均年龄:53.0 岁)和 20 名对照组参与者。SMID组的血清25(OH)D水平明显高于对照组,口服SMID组的血清25(OH)D水平明显高于管饲SMID组。在管饲SMID组中,维生素D摄入量低于每日推荐摄入量,且与血清25(OH)D水平相关。管饲组的维生素 K 每日摄入量低于建议摄入量,但与血清维生素 K 水平无关。SMID组的血清ucOC水平明显高于对照组。管饲与血清 25(OH)D 水平呈明显正相关。血清25(OH)D水平与血清维生素K1水平无关:SMID组的ucOC水平高于对照组,这可能是由于日常维生素K和D缺乏所致。建议补充维生素D以降低ucOC水平。
{"title":"Serum 25(OH)D and vitamin K1 levels in patients with severe motor and intellectual disability: A Japanese single-center experience","authors":"","doi":"10.1016/j.braindev.2024.06.001","DOIUrl":"10.1016/j.braindev.2024.06.001","url":null,"abstract":"<div><h3>Purpose</h3><p><span>To investigate whether patients with severe motor and intellectual disability (SMID) have nutritional </span>vitamin D<span> and K insufficiencies and clarify the required vitamin supplementation.</span></p></div><div><h3>Methods</h3><p><span>This prospective observational study enrolled Japanese adults with SMID receiving institutionalized care who underwent blood sampling<span> between February 2020 and February 2022 during annual medical checkups. Serum vitamin K</span></span><sub>1</sub><span> and 25-hydroxy vitamin D<span> (25(OH)D) levels were measured to determine their relationship with serum uncarboxylated osteocalcin<span> (ucOC) levels. Vitamin D and K intake was compared among tube-fed and oral-intake patients with SMID and control participants using corresponding serum levels.</span></span></span></p></div><div><h3>Results</h3><p><span>The study included 124 patients with SMID (56 men and 68 women; mean age: 53.0 years) and 20 control participants. Serum 25(OH)D levels were significantly higher in the SMID group than in the control group and the oral intake SMID group than in the tube-fed SMID group. In the tube-fed SMID group, vitamin D<span><span> intake was lower than the daily recommended intake and correlated with serum 25(OH)D levels. Daily vitamin K intake in the tube-fed group was lower than recommended but not correlated with serum vitamin </span>K levels<span>. Serum ucOC levels were significantly higher in the SMID group than in the control group. Tube feeding was significantly and positively correlated with serum 25(OH)D levels. Serum 25(OH)D levels were not correlated with serum vitamin K</span></span></span><sub>1</sub> levels.</p></div><div><h3>Conclusions</h3><p>The SMID group had higher ucOC levels than the control group, possibly owing to daily vitamin K and D deficiencies. Vitamin D supplementation is recommended to decrease ucOC levels.</p></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"46 8","pages":"Pages 268-273"},"PeriodicalIF":1.4,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141322130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glucose instability and outcomes of neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia 接受治疗性低温的缺氧缺血性脑病新生儿的血糖不稳定性和预后。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-05-22 DOI: 10.1016/j.braindev.2024.05.003

Background

To investigate the prevalence and associated outcomes of glucose abnormalities in infants with hypoxic ischemic encephalopathy (HIE) undergoing therapeutic hypothermia (TH).

Methods

Glucose values were reviewed in all HIE infants. Pearson’s correlation was used to assess the association of hypo- and hyperglycemic episodes with neonatal brain MRI and neurodevelopmental outcomes (NDO) at 12 & 24 months.

Results

Of 153 infants included, 31, 56 and 43 had episodes of hypo-, hyperglycemia and combined, respectively. Hyperglycemia and combined hypo/hyper had higher mortality (p = 0.035), seizures (p = 0.009), and longer hospitalization (p = 0.023). Hypo- and hyperglycemia were associated with parenchymal hemorrhages (p = 0.028 & p = 0.027, respectively). Hypoglycemia was associated with restricted diffusion (p = 0.014), while hyperglycemia was associated with cortical injuries (p = 0.045). Each hour of hyper- or hypoglycemia was associated with 5.2–5.8 times unfavorable outcomes (p < 0.001).

Conclusion

Blood glucose aberrations were detrimental in HIE infants treated with TH. Optimizing glucose management is crucial in this setting.

背景:研究接受治疗性低温(TH)的缺氧缺血性脑病(HIE)婴儿血糖异常的发生率和相关结果:研究接受治疗性低温(TH)的缺氧缺血性脑病(HIE)婴儿血糖异常的发生率和相关结果:方法:对所有 HIE 婴儿的血糖值进行复查。方法:对所有 HIE 婴儿的血糖值进行复查,采用皮尔逊相关性评估低血糖和高血糖发作与新生儿脑磁共振成像及 12 个月和 24 个月的神经发育结果(NDO)之间的关联:在纳入的 153 名婴儿中,分别有 31、56 和 43 名婴儿出现低血糖、高血糖和合并低血糖。高血糖和合并低血糖/高血糖的婴儿死亡率较高(p = 0.035),癫痫发作率较高(p = 0.009),住院时间较长(p = 0.023)。低血糖和高血糖与脑实质出血有关(分别为 p = 0.028 和 p = 0.027)。低血糖与扩散受限有关(p = 0.014),而高血糖与皮质损伤有关(p = 0.045)。每一个小时的高血糖或低血糖都会导致5.2-5.8倍的不良后果(p 结论:血糖畸变对人体有害:血糖异常对接受 TH 治疗的 HIE 婴儿不利。在这种情况下,优化血糖管理至关重要。
{"title":"Glucose instability and outcomes of neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia","authors":"","doi":"10.1016/j.braindev.2024.05.003","DOIUrl":"10.1016/j.braindev.2024.05.003","url":null,"abstract":"<div><h3>Background</h3><p>To investigate the prevalence and associated outcomes of glucose abnormalities in infants with hypoxic ischemic encephalopathy (HIE) undergoing therapeutic hypothermia (TH).</p></div><div><h3>Methods</h3><p>Glucose values were reviewed in all HIE infants. Pearson’s correlation was used to assess the association of hypo- and hyperglycemic episodes with neonatal brain MRI and neurodevelopmental outcomes (NDO) at 12 &amp; 24 months.</p></div><div><h3>Results</h3><p>Of 153 infants included, 31, 56 and 43 had episodes of hypo-, hyperglycemia<span> and combined, respectively. Hyperglycemia and combined hypo/hyper had higher mortality (p = 0.035), seizures<span> (p = 0.009), and longer hospitalization (p = 0.023). Hypo- and hyperglycemia<span><span> were associated with parenchymal hemorrhages (p = 0.028 &amp; p = 0.027, respectively). Hypoglycemia was associated with restricted diffusion (p = 0.014), while hyperglycemia was associated with cortical </span>injuries (p = 0.045). Each hour of hyper- or hypoglycemia was associated with 5.2–5.8 times unfavorable outcomes (p &lt; 0.001).</span></span></span></p></div><div><h3>Conclusion</h3><p>Blood glucose aberrations were detrimental in HIE infants treated with TH. Optimizing glucose management is crucial in this setting.</p></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"46 8","pages":"Pages 262-267"},"PeriodicalIF":1.4,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141089140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JSCN Best Paper Awards JSCN 最佳论文奖
IF 1.7 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-05-13 DOI: 10.1016/S0387-7604(24)00066-4
{"title":"JSCN Best Paper Awards","authors":"","doi":"10.1016/S0387-7604(24)00066-4","DOIUrl":"https://doi.org/10.1016/S0387-7604(24)00066-4","url":null,"abstract":"","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"46 6","pages":"Page I"},"PeriodicalIF":1.7,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0387760424000664/pdfft?md5=2eb86c8e4a114f65e0e46037c645a0a6&pid=1-s2.0-S0387760424000664-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140914038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover 封面
IF 1.7 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-05-13 DOI: 10.1016/S0387-7604(24)00067-6
{"title":"Cover","authors":"","doi":"10.1016/S0387-7604(24)00067-6","DOIUrl":"https://doi.org/10.1016/S0387-7604(24)00067-6","url":null,"abstract":"","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"46 6","pages":"Page IBC"},"PeriodicalIF":1.7,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0387760424000676/pdfft?md5=5f9d9469da75fd5d4daddf02ff1d66f3&pid=1-s2.0-S0387760424000676-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140914039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variation in neuroimaging and outcomes in patients with Sturge Weber syndrome Type III Sturge Weber 综合征 III 型患者的神经影像学差异和预后。
IF 1.7 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-05-12 DOI: 10.1016/j.braindev.2024.05.001
Aristides Hadjinicolaou , Aisling Quinlan , Shanshan Liu , Bo Zhang , Masanori Takeoka , Mustafa Sahin , Sanjay P Prabhu , Anna Lecticia Pinto

Objectives

Sturge Weber syndrome (SWS) is a neurovascular condition with an estimated incidence of 1 in 20,000 to 50,000 live births. SWS Types I and II involve cutaneous and ophthalmological findings, with neurological involvement in Type I. SWS Type III is exclusive to brain stigmata. Our study aims to describe the characteristics of brain MRI findings and report neuroradiological features with seizure and cognitive outcomes in patients with SWS Type III.

Methods

This is a retrospective case series examining the clinical, radiological, and cognitive characteristics of patients with SWS Type III referred to the SWS Clinic at Boston Children’s Hospital. We analyzed brain MRI findings based on vascular and parenchymal features. Clinical and cognitive outcomes were based on a validated assessment tool in this population (Neuroscore).

Results

This dedicated case series of patients with Type III SWS from a single center identified ten patients. All patients had classic stigmata indicative of SWS. Two distinct radiological phenotypes were found, one characterized by more pronounced deep venous enlargement, and the other, with more pronounced parenchymal abnormalities. There was heterogeneity in seizure presentation and outcome. Earlier age of onset and seizures predict more severe outcomes, as seen in classic SWS.

Conclusion

We could not find significant divergence in outcomes between patients with differing neuroimaging phenotypes. These results raise the question of whether the two distinct radiological phenotypes found in SWS Type III are reflective of different disease entities, with underlying genetic heterogeneity. These results suggest the need for larger, multi-center natural history studies.

目的:韦伯综合征(Sturge Weber Syndrome,SWS)是一种神经血管疾病,估计发病率为每 2 万至 5 万活产婴儿中就有 1 例。SWS I 型和 II 型涉及皮肤和眼科,I 型涉及神经系统。我们的研究旨在描述 SWS III 型患者脑部 MRI 检查结果的特征,并报告神经放射学特征与癫痫发作和认知结果的关系:这是一项回顾性病例系列研究,考察了转诊至波士顿儿童医院 SWS 诊所的 SWS III 型患者的临床、放射学和认知特征。我们根据血管和实质特征对脑磁共振成像结果进行了分析。临床和认知结果基于该人群的有效评估工具(Neuroscore):该病例系列专门针对来自一个中心的III型SWS患者,共发现10例患者。所有患者都有SWS的典型症状。发现了两种不同的放射学表型,一种以更明显的深静脉扩张为特征,另一种以更明显的实质异常为特征。癫痫发作表现和预后存在异质性。发病年龄较早和癫痫发作预示着更严重的预后,这在典型的 SWS 中可见一斑:结论:我们没有发现不同神经影像表型患者的预后存在明显差异。这些结果提出了一个问题:在 SWS III 型中发现的两种不同的放射学表型是否反映了不同的疾病实体,以及潜在的遗传异质性。这些结果表明有必要进行更大规模的多中心自然史研究。
{"title":"Variation in neuroimaging and outcomes in patients with Sturge Weber syndrome Type III","authors":"Aristides Hadjinicolaou ,&nbsp;Aisling Quinlan ,&nbsp;Shanshan Liu ,&nbsp;Bo Zhang ,&nbsp;Masanori Takeoka ,&nbsp;Mustafa Sahin ,&nbsp;Sanjay P Prabhu ,&nbsp;Anna Lecticia Pinto","doi":"10.1016/j.braindev.2024.05.001","DOIUrl":"10.1016/j.braindev.2024.05.001","url":null,"abstract":"<div><h3>Objectives</h3><p>Sturge Weber syndrome (SWS) is a neurovascular condition with an estimated incidence of 1 in 20,000 to 50,000 live births. SWS Types I and II involve cutaneous and ophthalmological findings, with neurological involvement in Type I. SWS Type III is exclusive to brain stigmata. Our study aims to describe the characteristics of brain MRI findings and report neuroradiological features with seizure and cognitive outcomes in patients with SWS Type III.</p></div><div><h3>Methods</h3><p>This is a retrospective case series examining the clinical, radiological, and cognitive characteristics of patients with SWS Type III referred to the SWS Clinic at Boston Children’s Hospital. We analyzed brain MRI findings based on vascular and parenchymal features. Clinical and cognitive outcomes were based on a validated assessment tool in this population (Neuroscore).</p></div><div><h3>Results</h3><p>This dedicated case series of patients with Type III SWS from a single center identified ten patients. All patients had classic stigmata indicative of SWS. Two distinct radiological phenotypes were found, one characterized by more pronounced deep venous enlargement, and the other, with more pronounced parenchymal abnormalities. There was heterogeneity in seizure presentation and outcome. Earlier age of onset and seizures predict more severe outcomes, as seen in classic SWS.</p></div><div><h3>Conclusion</h3><p>We could not find significant divergence in outcomes between patients with differing neuroimaging phenotypes. These results raise the question of whether the two distinct radiological phenotypes found in SWS Type III are reflective of different disease entities, with underlying genetic heterogeneity. These results suggest the need for larger, multi-center natural history studies.</p></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"46 7","pages":"Pages 244-249"},"PeriodicalIF":1.7,"publicationDate":"2024-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140917029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrauterine twin environment and genetic factors subliminally affecting general movements in preterm infants 宫内双胞胎环境和遗传因素潜移默化地影响早产儿的一般运动。
IF 1.4 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-05-04 DOI: 10.1016/j.braindev.2024.05.002

Background

Understanding background factors is beneficial for interpreting general movements (GMs). This study examines the factors involved in preterm-writhing GMs by comparing twins and singletons.

Method

The subjects were 107 infants cared for at Oita University. The cohort consisted of very-low-birth-weight infants, including twins with a birth weight < 2000 g. The median gestational age (GA) was 29 weeks 1 day. The subjects consisted of 75 singletons, 32 twins (16 pairs), 20 monochorionic twins (M−twins), and 12 dichorionic twins (D-twins). GMs were scored according to the GMs optimality score (GMOS) and integrated into 6 items: the quality, neck-trunk and space, amplitude-speed, rotation, onset-offset and cramped, and tremulous score at 32–34 weeks, 35–36 weeks, and 37–42 weeks’ GA. A hierarchical cluster analysis was performed using integrated GMOS, and the characteristics of clusters were examined according to clinical backgrounds.

Results

Three clusters were identified. Cluster 1 was characterized by good-quality GMs, cluster 2 by a poor repertoire but optimal space and rotatory components, and cluster 3 by overall poor-quality GMs, respectively. The mean GMOSs were 36.6, 31.8 and 24.3 in clusters 1, 2, and 3, respectively. There were no marked differences in proportions within clusters with respect to sex and twins. Small-for-gestational age (SGA) was significantly more frequent in cluster 3 at 32–34 weeks’ GA than in other clusters. Perinatal brain injury had a significantly lower proportion in cluster 1 and a higher proportion in cluster 3 at 35–36 weeks’ GA and 37–42 weeks’ GA. M−twin pairs tended to belong to the same clusters at 35–36 weeks’ GA.

Conclusion

Preterm writhing GMs are associated with SGA and perinatal brain injury. Cluster matching in M−twins suggests that certain genetic factors may substantially influence GMs.

背景:了解背景因素有利于解释全身运动(GMs)。本研究通过比较双胞胎和单胎婴儿,研究了早产儿一般动作的相关因素:研究对象是大分大学护理的 107 名婴儿。方法:研究对象为大分大学护理的 107 名婴儿,其中包括出生体重结果为极低体重的双胞胎:确定了三个群组。群组 1 的特征分别是高质量的 GM,群组 2 的特征是较差的重奏但有最佳的空间和旋转成分,群组 3 的特征是总体质量较差的 GM。第 1、2 和 3 组的平均 GMOS 分别为 36.6、31.8 和 24.3。群组内的性别和双胞胎比例没有明显差异。与其他群组相比,第 3 群组中 32-34 周胎儿的小于胎龄(SGA)发生率明显更高。围产期脑损伤在第 1 组中的比例明显较低,而在第 3 组中,胎龄在 35-36 周和 37-42 周的比例较高。在35-36周龄时,M-双胎往往属于同一个群组:结论:早产儿蠕动性GM与SGA和围产期脑损伤有关。早产儿扭体与 SGA 和围产期脑损伤有关。M-双胞胎的聚类匹配表明,某些遗传因素可能对早产儿扭体有重大影响。
{"title":"Intrauterine twin environment and genetic factors subliminally affecting general movements in preterm infants","authors":"","doi":"10.1016/j.braindev.2024.05.002","DOIUrl":"10.1016/j.braindev.2024.05.002","url":null,"abstract":"<div><h3>Background</h3><p>Understanding background factors is beneficial for interpreting general movements (GMs). This study examines the factors involved in preterm-writhing GMs by comparing twins and singletons.</p></div><div><h3>Method</h3><p>The subjects were 107 infants cared for at Oita University. The cohort consisted of very-low-birth-weight infants, including twins with a birth weight &lt; 2000 g. The median gestational age (GA) was 29 weeks 1 day. The subjects consisted of 75 singletons, 32 twins (16 pairs), 20 monochorionic twins (M−twins), and 12 dichorionic twins (D-twins). GMs were scored according to the GMs optimality score (GMOS) and integrated into 6 items: the quality, neck-trunk and space, amplitude-speed, rotation, onset-offset and cramped, and tremulous score at 32–34 weeks, 35–36 weeks, and 37–42 weeks’ GA. A hierarchical cluster analysis was performed using integrated GMOS, and the characteristics of clusters were examined according to clinical backgrounds.</p></div><div><h3>Results</h3><p>Three clusters were identified. Cluster 1 was characterized by good-quality GMs, cluster 2 by a poor repertoire but optimal space and rotatory components, and cluster 3 by overall poor-quality GMs, respectively. The mean GMOSs were 36.6, 31.8 and 24.3 in clusters 1, 2, and 3, respectively. There were no marked differences in proportions within clusters with respect to sex and twins. Small-for-gestational age (SGA) was significantly more frequent in cluster 3 at 32–34 weeks’ GA than in other clusters. Perinatal brain injury had a significantly lower proportion in cluster 1 and a higher proportion in cluster 3 at 35–36 weeks’ GA and 37–42 weeks’ GA. M−twin pairs tended to belong to the same clusters at 35–36 weeks’ GA.</p></div><div><h3>Conclusion</h3><p>Preterm writhing GMs are associated with SGA and perinatal brain injury. Cluster matching in M−twins suggests that certain genetic factors may substantially influence GMs.</p></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"46 8","pages":"Pages 255-261"},"PeriodicalIF":1.4,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S038776042400072X/pdfft?md5=49185dd664dcddddccdf034c21918521&pid=1-s2.0-S038776042400072X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adolescent-onset epilepsy and deterioration associated with CAD deficiency: A case report 青少年癫痫和病情恶化与 CAD 缺乏症有关:病例报告
IF 1.7 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-04-18 DOI: 10.1016/j.braindev.2024.04.001
Sebastián Silva , Mónica Rosas , Benjamín Guerra , Marión Muñoz , Atsushi Fujita , Masamune Sakamoto , Naomichi Matsumoto

Introduction

CAD (MIM*114010) encodes a large multifunctional protein with the enzymatic activity of the first three enzymes initiating and controlling the de novo pyrimidine biosynthesis pathway. Biallelic pathogenic variants in CAD cause the autosomal recessive developmental and epileptic encephalopathy 50 (MIM #616457) or CAD deficiency presenting with epilepsy, status epilepticus (SE), neurological deterioration and anemia with anisopoikilocytosis. Mortality is around 9% of patients, mainly related to the no use of its specific treatment with uridine. Majority of reported cases have an early onset during infancy, with some few starting later in childhood.

Case report

Here we report a deceased female patient with CAD deficiency whose epilepsy started at 14 years. She showed a rapid neurologic deterioration including cognitive decline, electroencephalographic background slowing which later evolved to a fatal refractory SE and supra and infratentorial atrophy on neuroimaging. Anemia developed after SE onset.

Methods and results

her post-mortem whole exome sequencing identified biallelic missense variants in CAD (NM_004341.5): c.[2944G > A];[5366G > A] p.[(Asp982Asn)];[(Arg1789Gln)]. Our review of twenty-eight reported cases (2015–2023) revealed an epilepsy age onset from neonatal period to 7 years and the SE prevalence of 46 %.

Discussion

With our case, we highlight the relevance of suspecting this treatable condition in older patients and in SE with no evident etiology.

导言CAD(MIM*114010)编码一种大型多功能蛋白质,具有启动和控制嘧啶从头生物合成途径的前三种酶的酶活性。CAD 的双倍拷贝致病变体会导致常染色体隐性发育性和癫痫性脑病 50(MIM #616457)或 CAD 缺乏症,表现为癫痫、癫痫状态(SE)、神经系统恶化和贫血伴无异形血小板增多。患者死亡率约为 9%,主要与未使用尿苷进行特异性治疗有关。大多数报告的病例在婴儿期早期发病,也有少数病例在儿童期晚些时候发病。她的神经系统状况迅速恶化,包括认知能力下降、脑电图背景变慢,后来演变为致命的难治性癫痫,神经影像学检查显示脑室上部和下部萎缩。方法和结果尸检全外显子测序发现了 CAD(NM_004341.5)的双偶缺失变异:c. [2944G > A]; [5366G > A] p. [(Asp982Asn)];[(Arg1789Gln)]。我们对 28 个报告病例(2015-2023 年)进行了回顾,发现癫痫的发病年龄从新生儿期到 7 岁不等,SE 的发病率为 46%。讨论通过我们的病例,我们强调了在老年患者和无明显病因的 SE 中怀疑这种可治疗疾病的相关性。
{"title":"Adolescent-onset epilepsy and deterioration associated with CAD deficiency: A case report","authors":"Sebastián Silva ,&nbsp;Mónica Rosas ,&nbsp;Benjamín Guerra ,&nbsp;Marión Muñoz ,&nbsp;Atsushi Fujita ,&nbsp;Masamune Sakamoto ,&nbsp;Naomichi Matsumoto","doi":"10.1016/j.braindev.2024.04.001","DOIUrl":"10.1016/j.braindev.2024.04.001","url":null,"abstract":"<div><h3>Introduction</h3><p><em>CAD</em> (MIM*114010) encodes a large multifunctional protein with the enzymatic activity of the first three enzymes initiating and controlling the de novo pyrimidine biosynthesis pathway. Biallelic pathogenic variants in <em>CAD</em> cause the autosomal recessive developmental and epileptic encephalopathy 50 (MIM #616457) or CAD deficiency presenting with epilepsy, status epilepticus (SE), neurological deterioration and anemia with anisopoikilocytosis. Mortality is around 9% of patients, mainly related to the no use of its specific treatment with uridine. Majority of reported cases have an early onset during infancy, with some few starting later in childhood.</p></div><div><h3>Case report</h3><p>Here we report a deceased female patient with CAD deficiency whose epilepsy started at 14 years. She showed a rapid neurologic deterioration including cognitive decline, electroencephalographic background slowing which later evolved to a fatal refractory SE and supra and infratentorial atrophy on neuroimaging. Anemia developed after SE onset.</p></div><div><h3>Methods and results</h3><p>her <em>post-mortem</em> whole exome sequencing identified biallelic missense variants in CAD (NM_004341.5): c.[2944G &gt; A];[5366G &gt; A] p.[(Asp982Asn)];[(Arg1789Gln)]. Our review of twenty-eight reported cases (2015–2023) revealed an epilepsy age onset from neonatal period to 7 years and the SE prevalence of 46 %.</p></div><div><h3>Discussion</h3><p>With our case, we highlight the relevance of suspecting this treatable condition in older patients and in SE with no evident etiology.</p></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"46 7","pages":"Pages 250-253"},"PeriodicalIF":1.7,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140757591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Brain & Development
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1